Literature DB >> 15720936

Isotretinoin, depression and suicide: a review of the evidence.

Parker Magin1, Dimity Pond, Wayne Smith.   

Abstract

There is currently considerable controversy regarding a proposed causal relationship between the use of isotretinoin and depression and suicide. A search was made of the MEDLINE, EMBASE and PsychINFO databases using the search terms 'isotretinoin', 'depression' and 'suicide'. Despite numerous case reports linking isotretinoin to depression, suicidal ideation and suicide, there is, as yet, no clear proof of an association. While isotretinoin, used to treat acne vulgaris, has not been demonstrated to be associated with depression or suicide, the possibility of a relatively rare idiosyncratic adverse effect remains. GPs have a role in the clinical application of these findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720936      PMCID: PMC1463189     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  61 in total

1.  Isotretinoin use and reports of sustained dreaming.

Authors:  M A Gupta; A K Gupta
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

2.  Depression and suicide in patients treated with isotretinoin.

Authors:  D K Wysowski; M Pitts; J Beitz
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

3.  Family physicians and accutane.

Authors:  D J Van Durme
Journal:  Am Fam Physician       Date:  2000-10-15       Impact factor: 3.292

4.  Scars: the battle over isotretinoin.

Authors:  J M Weinberg
Journal:  Cutis       Date:  2001-07

5.  Methodological limitations of the study "Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide".

Authors:  D K Wysowski; J Beitz
Journal:  Arch Dermatol       Date:  2001-08

6.  Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

Authors:  J S Strauss; J J Leyden; A W Lucky; D P Lookingbill; L A Drake; J M Hanifin; N J Lowe; T M Jones; D M Stewart; M T Jarratt; I Katz; D M Pariser; R J Pariser; E Tschen; D K Chalker; E S Rafal; R P Savin; H L Roth; L K Chang; D J Baginski; S Kempers; J McLane; D Eberhardt; E E Leach; G Bryce; J Hong
Journal:  J Am Acad Dermatol       Date:  2001-08       Impact factor: 11.527

7.  Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study.

Authors:  A Smithard; C Glazebrook; H C Williams
Journal:  Br J Dermatol       Date:  2001-08       Impact factor: 9.302

8.  Isotretinoin use in acne: prospective evaluation of adverse events.

Authors:  P R Hull ; C Demkiw-Bartel
Journal:  J Cutan Med Surg       Date:  2000-04       Impact factor: 2.092

9.  Adolescent depressive disorder: a population-based study of ICD-10 symptoms.

Authors:  G C Patton; C Coffey; M Posterino; J B Carlin; R Wolfe
Journal:  Aust N Z J Psychiatry       Date:  2000-10       Impact factor: 5.744

10.  Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.

Authors:  S S Jick; H M Kremers; C Vasilakis-Scaramozza
Journal:  Arch Dermatol       Date:  2000-10
View more
  14 in total

Review 1.  [Systemic acne therapy].

Authors:  A Thielitz; H Gollnick
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

2.  Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel "patient symptom survey" approach.

Authors:  Chelsea J Hodgkiss-Harlow; Lawrence F Eichenfield; Magdalene A Dohil
Journal:  J Am Acad Dermatol       Date:  2011-05-31       Impact factor: 11.527

3.  Comparison of Quality of Life, Depression, Anxiety, Suicide, Social Anxiety and Obsessive-Compulsive Symptoms Between Adolescents with Acne Receiving Isotretinoin and Antibiotics: A Prospective, Non-randomised, Open-Label Study.

Authors:  Yakup Erdoğan; İjlal Erturan; Evrim Aktepe; Abdulbaki Akyıldız
Journal:  Paediatr Drugs       Date:  2019-06       Impact factor: 3.022

4.  Can oral isotretinoin be safely initiated and monitored in primary care? A case series.

Authors:  D Buckley; S Yoganathan
Journal:  Ir J Med Sci       Date:  2017-01-09       Impact factor: 1.568

Review 5.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 6.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

Review 7.  Acne vulgaris.

Authors:  Sarah Purdy; David Deberker
Journal:  BMJ Clin Evid       Date:  2008-05-15

Review 8.  Assessing the role of drugs in suicidal ideation and suicidality.

Authors:  David M Reith; Liza Edmonds
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Acne vulgaris.

Authors:  Sarah Purdy; David de Berker
Journal:  BMJ Clin Evid       Date:  2011-01-05

10.  Isotretinoin in Acne Vulgaris Complicated by Underlying Major Depression: A Case Report and Review of Literature.

Authors:  Matthew DeLuca; Maxsaya Baez Nuñez; Ezequiel Rodriguez; Krishan Chirimunj
Journal:  Case Rep Psychiatry       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.